Alterity Therapeutics Ltd News

Alterity Therapeutics Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Oct 31 09:11

Alterity Therapeutics Ltd: Notice of Annual General Meeting

Oct 23 06:56

Alterity Therapeutics Ltd: ATH to Participate in 2024 Maxim Healthcare Virtual Summit

Oct 14 08:07

Alterity Therapeutics Ltd: Alterity Presents Data Describing Neuroprotection of ATH434

Oct 11 06:36

Alterity Therapeutics Ltd: Change of Share Registry

Oct 4 11:05

Alterity Therapeutics Ltd: Alterity Data Presentations at MDS Congress Raises Profile

Oct 2 09:43

Alterity Therapeutics Ltd: Alterity Therapeutics Filed Form 20-F and XBRL data with SEC

Sep 30 11:32

Alterity Therapeutics Ltd: ATH Appoints Abby Macnish Niven as Chief Financial Officer

Sep 30 07:00

Alterity Therapeutics Ltd: Appendix 4G

Sep 26 11:20

Alterity Therapeutics Ltd: Corporate Governance Statement

Sep 26 11:15

Alterity Therapeutics Ltd: Annual Report 2024

Sep 26 11:09

Alterity Therapeutics Ltd: Alterity to Deliver Multiple Presentations at MDS Congress

Sep 23 07:33

Alterity Therapeutics Ltd: Change of Director's Interest Notice - BM / PM

Sep 20 06:17

Alterity Therapeutics Ltd: Notification of cessation of securities - ATH

Sep 2 09:41

Alterity Therapeutics Ltd: Appendix 4E Preliminary Final Report

Aug 29 11:23

Alterity Therapeutics Ltd: Notification of cessation of securities - ATH

Aug 1 06:35

Alterity Therapeutics Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Jul 31 06:12

Alterity Therapeutics Ltd: Alterity Therapeutics to Present at MST Financial Webinar

Jul 24 09:15

Alterity Therapeutics Ltd: Notice Under Section 708A

Jul 19 10:19

Alterity Therapeutics Ltd: Application for quotation of securities - ATH

Jul 19 10:17